Mohamed El Zein-ahmed, MD | |
2520 5th Street N., Columbus, MS 39705 | |
(662) 244-2042 | |
(662) 244-2041 |
Full Name | Mohamed El Zein-ahmed |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 2520 5th Street N., Columbus, Mississippi |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376596932 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 13710 (Mississippi) | Primary |
Entity Name | St. Dominic Hospital Medicine Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104362292 PECOS PAC ID: 5597034348 Enrollment ID: O20170711000091 |
News Archive
Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.
Billy Beane's data-driven strategies made him the talk of baseball, the king of the current box office and a highly visible advocate for evidence-based medicine. But Beane's teams have faded since their "Moneyball" heyday -; and evidence-based medicine might not be the home run that some reformers hope it will be.
Cardiovascular disease (also called heart disease) is one of the most common medical conditions older adults face. In nursing homes, almost half of all older adult residents have been diagnosed with problems affecting the heart and/or blood vessels.
MannKind Corporation has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Afresa (insulin monomer human [rDNA origin]) Inhalation Powder and the Afresa Inhaler for the treatment of adults with type 1 or type 2 diabetes mellitus for the control of hyperglycemia.
The poor diet of shift workers should be considered a new occupational health hazard, according to an editorial published in this month's PLoS Medicine.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mohamed El Zein-ahmed, MD Po Box 22727, Jackson, MS 39225-2727 Ph: (601) 200-4880 | Mohamed El Zein-ahmed, MD 2520 5th Street N., Columbus, MS 39705 Ph: (662) 244-2042 |
News Archive
Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors (GPCRs) promotes prostate cancer cell growth. The protein, GPR158, was found while the researchers were looking for new drug targets for glaucoma.
Billy Beane's data-driven strategies made him the talk of baseball, the king of the current box office and a highly visible advocate for evidence-based medicine. But Beane's teams have faded since their "Moneyball" heyday -; and evidence-based medicine might not be the home run that some reformers hope it will be.
Cardiovascular disease (also called heart disease) is one of the most common medical conditions older adults face. In nursing homes, almost half of all older adult residents have been diagnosed with problems affecting the heart and/or blood vessels.
MannKind Corporation has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Afresa (insulin monomer human [rDNA origin]) Inhalation Powder and the Afresa Inhaler for the treatment of adults with type 1 or type 2 diabetes mellitus for the control of hyperglycemia.
The poor diet of shift workers should be considered a new occupational health hazard, according to an editorial published in this month's PLoS Medicine.
› Verified 3 days ago
Fakhri Dalati, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 5th St N, Columbus, MS 39705 Phone: 662-244-2042 Fax: 662-244-2041 | |
Dr. Connie Harris Scurti, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd Ste 301, Columbus, MS 39705 Phone: 662-244-1705 Fax: 662-227-4301 | |
Dr. Michael R Duckworth, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2225 5th St N, Columbus, MS 39705 Phone: 662-327-0197 Fax: 662-327-5660 | |
Michael J Boland, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd, Suite 402, Columbus, MS 39705 Phone: 662-240-1412 Fax: 662-240-1949 | |
Dr. Madhukar Saran, M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 824 Alabama St, Columbus, MS 39702 Phone: 662-244-0391 Fax: 662-244-0395 | |
Dr. Paul J Scurti, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd Ste 301, Columbus, MS 39705 Phone: 662-244-1705 Fax: 662-227-4301 | |
Wail Alnas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 345 Baptist Blvd, Columbus, MS 39705 Phone: 662-244-2288 Fax: 662-244-2763 |